February 2009 – Acquisition of oritavancin

February 2009 – Acquisition of oritavancin, a novel antibiotic intended for serious acute skin infections, from Targanta Therapeutics Corporation.

Date: 
Sunday, February 1, 2009
Category: 
Infectious Disease